Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
- Linguistics
- Business
- Medical Sciences
- Economics
- Computer Science
- Engineering
- Biology
- Social Sciences
- Psychology
- Sports and Recreation
- Mathematics
- Education
- Materials Science
- Environment
- Law
- Science
- Arts and Literature
- Electrical Engineering
- Chemistry
- Philosophy
- Earth Sciences
- Humanities
- 12 more »
- « less
-
accommodations for any part of the application process may contact, in confidence, accessibilityrequest.hr@mcgill.ca .
-
equity program and encourages members of designated groups to self-identify. Persons with disabilities who anticipate needing accommodations for any part of the application process may contact, in
-
assessments and related processes comply with Faculty and University regulations, while coordinating scheduling, materials management, invigilation logistics, and grade processing. The Coordinator also provides
-
of designated groups to self-identify. Persons with disabilities who anticipate needing accommodations for any part of the application process may contact, in confidence, accessibilityrequest.hr@mcgill.ca .
-
for any part of the application process may contact, in confidence, accessibilityrequest.hr@mcgill.ca .
-
who anticipate needing accommodations for any part of the application process may contact, in confidence, accessibilityrequest.hr@mcgill.ca .
-
. Persons with disabilities who anticipate needing accommodations for any part of the application process may contact, in confidence, accessibilityrequest.hr@mcgill.ca .
-
to self-identify. Persons with disabilities who anticipate needing accommodations for any part of the application process may contact, in confidence, accessibilityrequest.hr@mcgill.ca .
-
: Reporting to the Director of Administration, the Program Administrator oversees the curriculum processes, from form collection through final approval, coordinates Faculty revisions to the Course Catalogue
-
treatment strategies that can work alongside existing immunomodulatory therapies to treat metastatic disease. We use advanced somatic mouse models of mammary carcinogenesis to model chronic systemic